Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 18 open reading frame 12 pseudogene is classified as a human pseudogene—nonfunctional DNA exhibiting sequence homology with the protein-coding gene C18orf12. Pseudogenes generally arise from mutations or duplications causing gene inactivation. They do not encode functional proteins and are not part of major molecular families such as receptors, enzymes, or channels. The gene has no known therapeutic relevance or direct biological functions, although pseudogenes in general may participate in genomic regulation, e.g., through microRNA interactions. No disease roles, drug interactions, or biomarker functions have been documented for this specific pseudogene. For structured data or target validation, note that this pseudogene is not a recommended therapeutic target, nor does it have established biological or pharmacological functions. Its inclusion in target lists is generally a result of legacy gene annotation systems and not evidence of therapeutic utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 18 open reading frame 12 pseudogene (ENSG00000254678).